昆明貴研藥業(yè)有限公司是一家專業(yè)從事鉑類抗腫瘤藥物生產(chǎn)和研發(fā)的企業(yè),主導(dǎo)產(chǎn)品為原料藥順鉑、卡鉑、奧沙利鉑,均通過國家GMP認(rèn)證并獲得歐洲藥典適用性證書(CEP)。公司還擁有奈達(dá)鉑、舒鉑、賽特鉑、甲啶鉑、鉑抗癌藥物關(guān)鍵中間體的制備技術(shù),同時(shí)開展鉑抗癌藥物制劑技術(shù)、新型鉑類與有機(jī)類抗癌藥物的研發(fā)。
Kunming Guiyan Pharmaceutical Co., Ltd. (KGP),is a company focusing on manufacturing and developing Pt-drugs. he main products: bulk drug, Cisplatin, Carboplatin, Oxaliplatin passed the Chinese national GMP authentication and got CEP certificates. The company produces Nedaplatin, Satraplatin, Picoplatin, the critical intermediate of Pt-drugs, The company is also exploring techniques to develop new Pt-drugs and organic antitumor drugs.
主導(dǎo)產(chǎn)品為順鉑、卡鉑、奧沙利鉑三個(gè)品種的原料藥,均通過國家GMP認(rèn)證并獲得歐洲藥典適用性證書(CEP)。
The three main products—bulk drug Cisplatin, Carboplatin and Oxaliplatin have passed the Chinese GMP authentication and have obtained the CEP.